Squarepoint Ops LLC - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 299 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.39 and the average weighting 0.2%.

Quarter-by-quarter ownership
Squarepoint Ops LLC ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$216,705
-97.9%
5,314
-98.1%
0.00%
-97.6%
Q1 2023$10,219,583
+221.4%
274,204
+200.9%
0.04%
+223.1%
Q4 2022$3,179,316
+803.2%
91,124
+1348.7%
0.01%
+550.0%
Q3 2022$352,000
-91.4%
6,290
-88.8%
0.00%
-88.2%
Q1 2022$4,074,000
-69.0%
56,057
-42.7%
0.02%
-55.3%
Q3 2021$13,129,000
+962.2%
97,871
+1182.5%
0.04%
+660.0%
Q2 2021$1,236,000
-49.4%
7,631
-83.0%
0.01%
-72.2%
Q4 2020$2,443,000
+67.8%
44,899
-38.7%
0.02%
-10.0%
Q3 2020$1,456,000
+28.6%
73,222
+35.9%
0.02%
+11.1%
Q2 2020$1,132,000
-2.7%
53,872
-21.0%
0.02%
+50.0%
Q1 2019$1,164,000
+12.9%
68,150
-9.7%
0.01%0.0%
Q4 2018$1,031,000
+10.9%
75,499
+132.3%
0.01%
+9.1%
Q3 2018$930,000
+26.7%
32,500
+21.1%
0.01%
+10.0%
Q2 2018$734,000
-19.8%
26,829
-38.2%
0.01%
-33.3%
Q1 2018$915,000
+46.6%
43,400
+33.6%
0.02%
+36.4%
Q4 2017$624,00032,4830.01%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Discovery Value Fund 561,561$17,756,5599.73%
MPM BioImpact LLC 544,639$17,221,4854.60%
Casdin Capital, LLC 1,178,075$37,250,7324.12%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,145,091$36,207,7773.72%
Atlas Venture Associates IX, LLC 10,000$316,2002.69%
Deep Track Capital, LP 2,000,000$63,240,0002.44%
ARK Investment Management 9,948,629$314,575,6382.41%
Merlin Capital, Inc 18,526$585,7922.19%
Orchard Capital Management, LLC 159,155$5,032,4811.86%
TANG CAPITAL MANAGEMENT LLC 397,600$12,572,1121.77%
View complete list of INTELLIA THERAPEUTICS INC shareholders